5-Aza-dc Treated Jurkat Genomic DNA

  • This product was discontinued on January 02, 2018

Ordering Information

  • Discontinued
  • Product Information
    Genomic DNA purified from human male Jurkat (human acute T-cell leukemia) cells that are treated with 5-aza-2-deoxycytidine (5-Aza-dc), suitable as a negative control in the study of CpG dinucleotide methylation in the genome.

    Product Source:

    Jurkat (acute T-cell leukemia) cells were grown to 50% confluency in RPMI plus 10% fetal bovine serum and were treated with a 2 µM 5-aza-2´-deoxycytidine for eight days. Genomic DNA was isolated by a standard genomic purification protocol (1), phenol/chloroform extracted and equilibrated to 10 mM Tris-HCl (pH 7.5) and 1 mM EDTA.
    Product Categories:
    • Advantages and Features
    • Properties and Usage
    • Notes
    • References
  • Protocols & Manuals
  • Quality & Safety
    • Quality Control Assays
    • Specifications
    • Certificate of Analysis
    • Safety Data Sheets
    • Datacards
  • Legal Information
    • Legal And Disclaimers
Loading Spinner